Buying Freeport-McMoRan (FCX)? Here's What You Must Know.

Shares of Freeport-McMoRan have moved 2.8% today, and are now trading at a price of $40.41. In contrast, the S&P 500 index saw a 0.0% change. Today's trading volume is 735,135 compared to the stock's average volume of 10,943,382.

Freeport-McMoRan Inc. engages in the mining of mineral properties in North America, South America, and Indonesia. Based in Phoenix, United States the company has 25,600 full time employees and a market cap of $58,619,170,816. Freeport-McMoRan currently offers its equity investors a dividend that yields 1.5% per year.

The company is now trading -11.61% away from its average analyst target price of $45.71 per share. The 19 analysts following the stock have set target prices ranging from $29.0 to $57.0, and on average give Freeport-McMoRan a rating of buy.

Over the last 52 weeks, FCX stock has risen 27.0%, which amounts to a 17.0% difference compared to the S&P 500. The stock's 52 week high is $46.73 whereas its 52 week low is $26.03 per share. Based on Freeport-McMoRan's average net margin growth of 5.6% over the last 6 years, its core business is on track for profitability and its strong stock performance may continue in the long term.

Date Reported Total Revenue ($ k) Net Profit ($ k) Net Margins (%) YoY Growth (%)
2023-02-15 22,780,000 3,468,000 15 -21.05
2022-02-15 22,845,000 4,306,000 19 375.0
2021-02-16 14,198,000 599,000 4 300.0
2020-02-14 14,402,000 -239,000 -2 -114.29
2019-02-15 18,628,000 2,602,000 14 27.27
2018-02-20 16,403,000 1,817,000 11
The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.